and adults [1] [2] [3] [4] [5] [6] [7] . Available data on the incidence and serotype distribution of circulating S. pneumoniae have been obtained by serologic determination of the capsular type after culture or by molecular typing of isolates [8] [9] [10] . However, the effectiveness of these methods is limited because of the need of bacterial growth, which in turn depends on a sufficient load of viable bacteria in biological samples. Children with pneumonia are at low risk of bacteremia [11, 12] ; furthermore, the use of antibiotic therapy on an outpatient basis at the beginning of a febrile episode significantly reduces the sensitivity of culture [13] .
Molecular methods applied on blood samples or other body fluids can be efficiently used for diagnosing and serotyping invasive pneumococcal disease [13] [14] [15] [16] [17] . These methods do not require viable bacteria, need small sample volumes, and appear more sensitive than cultural methods; therefore, they could be a useful tool in the diagnosis and serotyping of pneumococcal pneumonia [18] . The aim of this study was to diagnose and serotype pneumococcal bacteremic pneumonia using real-time polymerase chain reaction (RT-PCR) directly on blood samples in a large cohort of Italian children hospitalized with CAP and to compare the sensitivity of molecular methods versus culturebased methods.
PATIENTS AND METHODS
Study design. This observational study was conducted from April 2007 through June 2009 in children admitted with a diagnosis of CAP to pediatric hospitals or pediatric wards of general hospitals in Italy. Hospitals from all Italian regions were invited to participate.
Case definition. Pneumonia was suspected on the basis of clinical signs, such as tachypnea and abnormal breath sounds, and was confirmed by chest radiographic examination or computed tomography [19] . In collaboration with radiologists, a pediatric pulmonologist with experience in radiology who was unaware of the clinical and laboratory findings of the patients evaluated radiographs and assigned standardized and mutually exclusive diagnoses that included focal, segmental, or lobar consolidation with or without pleural effusion, interstitial pneumonia, atelectasis, or necrotizing pneumonia.
Complicated CAP was defined as the presence of у1 of the following: parapneumonic effusion defined as loculated pleural fluid on a chest radiograph film, a chest ultrasonogram, or computed tomography; any pleural fluid parameters consistent with empyema [19] ; and/or atelectasis or necrotizing pneumonia [20] . Children were considered to be fully vaccinated if they had completed the national vaccination schedule, including 3 doses of the 7-valent conjugate anti-pneumococcal conjugate vaccine (PCV-7) at 3, 5, and 12 months or a single dose after the first year of life. Children were considered to be incompletely vaccinated if they had started but not completed the vaccine schedule.
Patients and blood samples. All patients aged 0-16 years admitted with a diagnosis of pneumonia to the participating centers during the study period were included in the study. The exclusion criteria were severe concomitant diseases (eg, kidney, liver, or cardiovascular disease, immunodepression, malabsorption syndrome, or neoplasia) and nosocomial acquired infections. To exclude the latter, children who had been admitted to the hospital or had been evaluated in the day hospital or emergency department in the previous 14 days were excluded from the study. Written informed consent was obtained from all parents or guardians. The study was approved by the local institutional review board.
Whole blood was obtained as soon as possible after hospital admission. Samples for RT-PCR were obtained from all patients; clinicians were allowed to choose when to also request blood cultures. For culture purposes, 4-6 mL of blood samples (up to 3 sets) were immediately sent to the local laboratory. Standardized procedures were used for collection and shipment of blood samples to local laboratories. Blood samples for molecular tests were sent at room temperature to the central laboratory (Immunology Laboratory, Anna Meyer Children's University Hospital, Florence, Italy) with use of a fast freepost carrier. The samples were delivered by the following day, and the molecular tests were performed within 2 h after delivery; 200 mL of whole blood (not spun down) was used for both diagnosis and serotyping by RT-PCR.
Diagnosis of bacteremic pneumococcal pneumonia. Diagnosis of laboratory-confirmed bacteremic pneumococcal pneumonia was performed in the presence of culture positive for S. pneumoniae and/or RT-PCR positive for the lytA gene, as described elsewhere [15] . The cycle threshold (C T ) value is the PCR cycle number (of 45) at which the measured fluorescent signal exceeds a calculated background threshold, identifying amplification of the target sequence. If there was no increase in fluorescent signal before the 45th cycle, the sample was assumed to be negative.
PCR specificity on whole blood had been preliminarily evaluated by testing blood samples drawn from 87 age-matched healthy controls. Pneumococcal DNA was never found in the blood of healthy children, either carriers or noncarriers of S. pneumoniae [21] .
Quantitative analysis of pneumococcal DNA. To quantify the amount of bacterial DNA present in each sample, standards were prepared as described elsewhere [12] with use of suspensions of S. pneumoniae in phosphate-buffered saline. The amount of bacterial DNA was obtained by direct extrapolation of the C T values to the amount of DNA [12, 22] as read from the concentration versus the C T standard curve.
Serotyping by RT-PCR. Twenty-one primer/probe sets targeting different regions of the CpsA gene specific for 21 serotypes were used as described elsewhere [15] . If no increase in fluorescent signal was observed before the 45th cycle for any of the sets but both lytA in RT-PCR and CpsA in end point PCR [14, 15] were positive, the sample was reported as nontypeable. PCV-7 serotypes, PCV-7-related serotypes, or nonvaccine serotypes (including 19A) were defined according to Hsu et al [23] .
Statistical analysis. Data were processed with the SPSSX 11.0 statistical package (SPSS); was considered to be P ! .05 statistically significant. Results were expressed as mean levels and standard deviations or as median and interquartile range ). The RT-PCR result was P p .034 positive in 45 patients (15.4%) in whom both culture and RT-PCR were performed and in 37 patients (7.6%) in whom culture was not performed.
Overall, 82 (10.9%) of the 753 patients had positive results for S. pneumoniae. Among them, 20 were aged !2 years (Table  3) . No difference in the rate of bacteremic pneumonia was found between younger or older patients with either method (Table 3) . Besides the 11 samples found positive for S. pneumoniae by culture, 3 of the 292 cultures tested positive for Staphylococcus epidermidis ( ) and Staphylococcus hominis n p 2 ( ); they were reported as "bacterial contamination" by n p 1 the laboratory microbiologist.
Association between complication and pneumococcal bacteremia. Demographic, clinical, and laboratory characteristics of the children according to demonstration of pneumococcal bacteremia by RT-PCR are given in Table 1 . Increased levels of C-reactive protein and/or white blood cell count and/or neutrophil blood count were associated with complicated cases and with pneumococcal origin (Tables 1  and 2 ). Both culture and RT-PCR positivity were significantly associated with complications (Table 2) .
Quantitative analysis of pneumococcal DNA. The median bacterial load was 2.16 log 10 copies/mL (range, 1-5.88 log 10 copies/mL). The bacterial load was significantly higher in culture-positive patients (median, 2.70 log 10 copies/mL [range, 1.60-5.88 log 10 copies/mL] vs 2.25 log 10 copies/mL [range, 1.60-2.88 log 10 copies/mL]; 95% CI, 0.06-1.16;
) and tended P p .031 to be higher in patients aged 12 years (Table 3) ; no difference in bacterial load was found between patients with complicated and noncomplicated pneumonia ( ). Serotype 1 P p .001 was only present in older children (12 years) and had a frequency of 42.6%. In younger children (!2 years) the distribution of pneumococcal serotypes was more homogenous, with frequencies ranging from 5.3% (serotypes 4, 5, and 18) to 15.8% (serotypes 19A and 19F Among the 73 children with S. pneumoniae serotyped via molecular methods, 25 were vaccinated, 3 were incompletely vaccinated, and 40 were nonvaccinated. The data were not available for 5. Pneumonia due to PCV-7 serotypes or PCV-7-related serotypes (13 of 73 serotyped cases; 17.8%) was only found in the group of nonvaccinated children. No difference in the rate of complicated pneumonia was present among the groups; 87 complications (22.5%) were observed in 387 nonvaccinated patients, and 58 complications (18.6%) were observed in 311 ( ) fully or partially vaccinated children. P p .252
DISCUSSION
The present study, performed on a large cohort of 1750 Italian children hospitalized for CAP in 83 hospitals in Italy, demonstrates a percentage of pneumococcal bacteremic pneumonia of 110% when RT-PCR is used directly on blood samples for diagnosis. RT-PCR appears significantly more sensitive than culture for diagnosis of bacteremic pneumococcal pneumonia.
RT-PCR is extremely sensitive, and its specificity is an important topic. In the present research, 2 different target genes (lytA and Cps) known to be the most specific [14, 15, 24] were used to increase the confidence in positivity. Moreover, we previously demonstrated that, using lytA as the target gene and RT-PCR, pneumococcal DNA is never found in the blood of healthy children, regardless of their carrier state [21] . Therefore, it seems that RT-PCR sensitivity does not come at the cost of reduced specificity.
Even though only 292 cases could be simultaneously studied by culture and RT-PCR, the present research demonstrates a frequency of pneumococcal bacteremic pneumonia higher (3.8%) than described elsewhere (1.6%-2%) [11, 25] . The difference may be dependent on the fact that, in the design of the study, clinicians were allowed to choose when to also request blood cultures, in addition to RT-PCR. As indicated, clinicians requested blood cultures more frequently in severe cases. The selection bias is in favor of culture sensitivity (and, therefore, it obviously goes toward the null hypothesis of the study, which was aimed to demonstrate the higher sensitivity of RT-PCR vs the culture-based method); nonetheless, the higher sensitivity of RT-PCR has been demonstrated. Actually, RT-PCR demonstrated a frequency of pneumococcal bacteremic pneumonia of ∼10% when all pneumonia cases are included, which increased up to 16% in the group of patients in whom molecular and cultural tests were performed simultaneously. In the clinical approach, on-the-field, molecular tests appear to have a sensitivity 4 times that of culture. The advantage may in part be attributable to the preadmission use of antibiotics, which undoubtedly reduces culture sensitivity [13] yet seems to have a lower effect on RT-PCR sensitivity, even though the difference does not reach statistical significance. The limited number of positive cultures did not permit statistical analyses; however, the distribution of culture-positive isolates in different serotypes suggests that the advantage of PCR is not serotype specific. The C-reactive protein level, white blood cell count, and/or neutrophil blood count were significantly associated with pneumococcal cause and complications. However, given the wide range and overlapping of values, those biomarkers can hardly be used to predict cause or complications in a single patient.
Quantitative analysis demonstrated, as expected, that bacterial load is significantly higher in culture-positive patients and tended to be higher in older children. On the contrary, no difference in bacterial load was found between patients with complicated versus noncomplicated pneumonia. It may be suggested that factors other than bacterial load, depending on the single serotype aggressiveness or on the host response, are more important in causing complications.
Serotype distribution demonstrated a large preponderance of serotype 1, followed by serotypes 19A and 3. The data obtained by serotyping directly from blood samples reached results consistent with those obtained by serotyping of isolates in western countries [26] . Serotype 1 appeared significantly associated with complications and older age. The important role of serotype 1 in all pneumonia cases and especially in complicated ones had been suggested by other reports [19, [26] [27] [28] ; the present data show for the first time, to our knowledge, that in Italy serotype 1 alone currently causes more than onethird of pneumococcal bacteremic pneumonia cases and 50% of complicated cases. Serotype 19A prevalence is 15%, with a significantly higher prevalence in younger children. Serotype 14, which represented one of the most frequent serotypes in Italy in the past decade [29, 30] now has a prevalence of !5%. A shift toward nonvaccine serotypes has been described after mass vaccination [31] and is associated with a decrease in the number of cases due to vaccine serotypes [3, 32] . This is not the case in Italy, where vaccination is limited to some regions, overall covering !30% of the country. Therefore, it is unlikely that a shift attributable to PCV-7 vaccination is the only cause for the serotype 1 and 19A increase. A spontaneous increase in serotype 1 frequency, as demonstrated in the prevaccination era in Belgium [33] and the secular trend demonstrated for different serotypes in the United States [34, 35] , may probably contribute to the phenomenon observed in Italy. PCV-7 serotypes were never found in fully or partially vaccinated children. However, at present, vaccines other than PCV-7 are needed in Italy. Actually, 165% of all pneumonia cases and 175% of complicated cases are due to serotypes that are not included in the PCV-7 but are included in the 13-valent formulation.
The present study showed a percentage of complicated CAP of 120%, consistent with results obtained in other western countries. In recent years, the percentage of complicated CAP has appeared to be growing in the world [25, 36, 37] , increasing from 14% to 26% in the United States [19] , and a role of aggressive serotypes of S. pneumoniae has been hypothesized. Our data demonstrate that pneumococcal bacteremia was 3 times more frequent in complicated CAP and that serotype 1 is prevalent. This finding is confirmed by the separate analysis on the group (177 patients) of younger children (aged !2 years), which showed that even though the rate of bacteremic pneumococcal pneumonia is similar to that of older children, the rate of complication is significantly lower. This is probably attributable to high frequency of more aggressive pneumococcal serotypes in older children, such as serotype 1, which was never found in children aged !2 years.
Another study [7] suggested that an expansion of a prevaccination clone more than new clones is responsible for the diffusion of complicated CAP due to serotype 1. Sequencing of bacterial DNA from the 26 cases due to serotype 1 is now ongoing in our laboratory to evaluate whether a similar condition is present in Italy.
Among the causes of CAP, S. pneumoniae, although presumably the most common bacterial cause, still remains underestimated because nonbacteremic pneumococcal CAP is probably the cause in most cases [6, 25, 38] . Surrogate biomarkers have been studied, but the search for specific antibodies or urine antigens has often produced frustrating results [39] [40] [41] [42] . Even though RT-PCR performed on blood samples cannot identify all pneumococcal pneumonia, being limited to finding bacteremic cases, it is undoubtedly an important tool in obtaining a reliable monitoring of circulating serotypes. Moreover, because of the high sensitivity of this method, using molecular serotyping directly on blood samples allows the acquisition of a higher number of bacteremic pneumococcal pneumonia in a narrower time window. Actually, given the frequency of culturepositive results demonstrated in the present study, a population of 13000 patients with pneumonia would probably have been necessary to get 80 positive cases with culture-based methods. RT-PCR is simple and known to be less expensive [15] than culture-based methods. In respect to multiplex sequential PCR, it could also be a further improvement [15] for countries in the developing world, where molecular methods have demonstrated [17, 43] a sensitivity that is significantly higher than that of culture-based methods.
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